Related Experiment Video

Updated: Feb 6, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.6K

Pulmonary Alveolar Proteinosis Related to Chronic Cotton Dust Exposure and Hepatitis-C Infection

Syed Zulkharnain Tousheed, Tiyas Sen Dutt, B V Muralimohan

    The Indian Journal of Chest Diseases & Allied Sciences
    |August 29, 2018
    PubMed

    Insights

    Pulmonary alveolar proteinosis developed in a patient with chronic dust exposure and hepatitis-C infection. Treatment involved modified bronchoalveolar lavage and granulocyte-monophase-colony stimulating factor.

    Area of Science:

    • Pulmonary Medicine
    • Toxicology
    • Infectious Diseases

    Background:

    • Chronic dust exposure is a known risk factor for various respiratory conditions.
    • Hepatitis-C infection can have systemic effects, potentially influencing lung health.
    • Pulmonary alveolar proteinosis (PAP) is a rare lung disorder characterized by surfactant accumulation.

    Observation:

    • A case of PAP is presented in a patient with a history of significant chronic dust exposure.
    • The patient also had a concurrent diagnosis of hepatitis-C infection.
    • This unique combination of factors prompted investigation into their potential interplay.

    Findings:

    • The patient was successfully managed using a modified bronchoalveolar lavage (BAL) technique.
    • Granulocyte-monophase-colony stimulating factor (GM-CSF) was administered as part of the therapeutic regimen.
    • The combined approach led to a positive clinical outcome in this complex case.

    Implications:

    • This case highlights the potential for chronic dust exposure and hepatitis-C to contribute to PAP development.
    • Modified BAL and GM-CSF may represent effective treatment options for similar complex PAP cases.
    • Further research is warranted to elucidate the mechanisms linking these conditions and optimize therapeutic strategies.

    More Related Videos

    In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure08:54

    In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

    Published on: October 22, 2019

    9.5K
    Experimental Methods of Dust Charging and Mobilization on Surfaces with Exposure to Ultraviolet Radiation or Plasmas07:54

    Experimental Methods of Dust Charging and Mobilization on Surfaces with Exposure to Ultraviolet Radiation or Plasmas

    Published on: April 3, 2018

    8.7K

    Related Concept Videos

    Chronic Obstructive Pulmonary Disease01:24

    Chronic Obstructive Pulmonary Disease

    COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
    Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
    2.6K
    Chronic Obstructive Pulmonary Disease-I: Introduction01:20

    Chronic Obstructive Pulmonary Disease-I: Introduction

    Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
    3.8K
    Chronic Obstructive Pulmonary Disease-V: Management01:29

    Chronic Obstructive Pulmonary Disease-V: Management

    Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
    Smoking Cessation
    3.2K
    Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

    Chronic Obstructive Pulmonary Disease-II: Pathophysiology

    Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
    Chronic Inflammation
    4.6K
    Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

    Chronic Obstructive Pulmonary Disease-V: Nursing Management

    Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
    Assessment
    5.2K
    Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

    Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

    Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
    Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
    Primary Symptoms of COPD:
    3.7K